Haleon plc
HLN
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include P… read more
Healthcare
Drug Manufacturers—Specialty & Generic
3 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$9.65
Price-0.52%
-$0.05
1Y
Price
Market Cap
$43.723b
Large
Price/Earnings 3y Avg5y Avg
21.4x
Premium
Premium
Financials Overview
Key metrics over the past few years+18.5%
EBITDA Margin+8.4%
Net Profit Margin-
Free Cash Flow MarginRevenue
$11.233b
-0.6%
1y CAGR+5.8%
3y CAGR+3.4%
5y CAGREarnings
$1.442b
+37.5%
1y CAGR+4.2%
3y CAGR+8.5%
5y CAGREPS
$9.43
+4186.4%
1y CAGR+1386.6%
3y CAGR+1046.2%
5y CAGRBook Value
$16.224b
$34.315b
Assets$18.091b
Liabilities$10.102b
DebtDebt to Assets
29.4%
4.2x
Debt to EBITDAFree Cash Flow
$0.00
-100.0%
1y CAGR-11.4%
3y CAGR-9.3%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in GBP.No items found.
Press Releases
Statements and updates from the company